Symptom interference with work and relationships during the menopausal transition and early postmenopause: Observations from the Seattle Midlife Women's Health Study

Menopause

Volumn 18, Issue 6, 2011, Pages 654-661

  Woods, Nancy Fugate ^a   Mitchell, Ellen Sullivan ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Early postmenopause; Interference; Menopausal transition; Symptoms

Indexed keywords

ESTRONE; ESTRONE GLUCURONIDE; FOLLITROPIN; HYDROCORTISONE; TESTOSTERONE;

ADULT; ANXIETY; ARTHRALGIA; ARTICLE; BACKACHE; CLIMACTERIUM; CONCENTRATION LOSS; ESTRONE BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HOT FLUSH; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MOOD; POSTMENOPAUSE; REPRODUCTION; STRESS; TESTOSTERONE BLOOD LEVEL; URINALYSIS; WAKEFULNESS;

ADULT; ANXIETY; BIOLOGICAL MARKERS; COMORBIDITY; DEPRESSION; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE, HUMAN; HEALTH STATUS; HOT FLASHES; HUMANS; HYDROCORTISONE; MEMORY DISORDERS; MIDDLE AGED; POSTMENOPAUSE; SEVERITY OF ILLNESS INDEX; SICK LEAVE; SLEEP DISORDERS; WASHINGTON; WOMEN'S HEALTH; WOMEN, WORKING; WORK SCHEDULE TOLERANCE; WORKLOAD;

EID: 79958776161     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e318205bd76     Document Type: Article

References (43)

1. Avis N, Ory M, Matthews K, Schocken M, Bromberger J, Colvin A. Health-related quality of life in a multiethnic sample of middle-aged women: Study of Women's Health Across the Nation (SWAN). Med Care 2003; 41: 1262-1276.
2. Avis N, Assmann S, Kravitz H, Ganz P, Ory M. Quality of life in diverse groups of midlife women: assessing the influence of menopause, health status, and psychosocial and demographic factors. Qual Life Res 2004; 13:933-946. (Pubitemid 39005103)
3. Avis NE, Colvin A, Bromberger JT, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation. Menopause 2009;16:860-869.
4. Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005;118:S14-S24.
5. Williams RE, Kalilani L, DiBenedetti DB, et al. Frequency and severity of vasomotor symptoms among peri-and postmenopausal women in the United States. Climacteric 2008;11:32-43.
6. Williams RE, Kalilani LK, DiBenedetti DB, Zhou X, Fehnel SE, Clark RV. Healthcare seeking and treatment for menopausal symptoms in the United States. Maturitas 2007;58:348-358. (Pubitemid 350167510)
7. Shifren JL, Schiff I. Role of hormone therapy in the management of menopause. Obstet Gynecol 2010;115:839-855.
8. Ockene JK, Barad DH, Cochrane BB, et al. Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005;294:183-193. (Pubitemid 41043788)
9. Brunner RL, Aragaki A, Barnabei V, et al. Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial. Menopause 2011; 17:946-954.
10. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995; 273:59-65.
11. Cleeland C. Symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr 2007;37:16-21.
12. Gapstur RL. Symptom burden: a concept analysis and implications for oncology nurses. Oncol Nurs Forum 2007;34:673-680.
13. Carpenter JS. The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 2001;22:979-989. (Pubitemid 33152683)
14. Woods NF, Mitchell ES, Percival DB, Smith-DiJulio K. Is the meno-pausal transition stressful? Observations of perceived stress from the Seattle Midlife Women's Health Study. Menopause 2009;16:90-97.
15. Pfaff D, Ribeiro A, Matthews J, Kow LM. Concepts and mechanisms of generalized central nervous system arousal. Ann N Y Acad Sci 2008; 1129:11-25. (Pubitemid 351990289)
16. Freedman RR, Benton MD, Genik RJ, Graydon FX. Cortical activation during menopausal hot flashes. Fertil Steril 2006;85:674-678. (Pubitemid 43261561)
17. Barsky AJ, Goodson JD, Lane RS, Cleary PD. The amplification of somatic symptoms. Psychosom Med 1988;50:510-519.
18. Carpenter JS, Rand KL. Modeling the hot flash experience in breast cancer survivors. Menopause 2008;15:469-475. (Pubitemid 351656751)
19. Mitchell ES, Woods NF, Mariella A. Three stages of the menopausal transition from the Seattle Midlife Women's Health Study: toward a more precise definition. Menopause 2000;7:334-349.
20. Harlow SD, Cain K, Crawford S, et al. Evaluation of four proposed bleeding criteria for the onset of late menopausal transition. J Clin Endocrinol Metab 2006;91:3432-3438. (Pubitemid 44402115)
21. Harlow SD, Mitchell ES, Crawford S, et al. The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition. Fertil Steril 2008;89:129-140.
22. Harlow SD, Crawford S, Dennerstein L, Burger HG, Mitchell ES, Sowers MF. ReSTAGE Collaboration. Recommendations from a multi-study evaluation of proposed criteria for staging reproductive aging. Climacteric 2007;10:112-119. (Pubitemid 46482175)
23. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril 2001;76:874-878. (Pubitemid 33031310)
24. Chiazze L Jr, Brayer FT, Macisco JJ Jr, Parker MP, Duffy BJ. The length and variability of the human menstrual cycle. JAMA 1968;203:377-380.
25. Denari JH, Farinati Z, Casas PR, Oliva A. Determination of ovarian function using first morning urine steroid assays. Obstet Gynecol 1981;58:5-9. (Pubitemid 11086853)
26. Stanczyk FZ, Miyakawa I, Goebelsmann U. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle. Am J Obstet Gynecol 1980;137:443-450. (Pubitemid 10073187)
27. O'Connor KA, Brindle E, Holman DJ, et al. Urinary estrone conjugate and pregnanediol 3-glucuronide enzyme immunoassays for population research. Clin Chem 2003;49:1139-1148. (Pubitemid 36751101)
28. Baker TE, Jennison KIM, Kellie AE. The direct radioimmunoassay of oestrogen glucuronides in human female urine. Biochem J 1979;177: 729-738. (Pubitemid 9141987)
29. Ferrell RJ, O'Connor KA, Holman DJ. Monitoring the transition to menopause in a five year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age. Menopause 2005;12:567-577. (Pubitemid 41362081)
30. O'Connor KA, Brindle E, Shofer JB, et al. Statistical correction for non-parallelism in a urinary enzyme immunoassay. J Immunoassay Immunochem 2004;25:259-278. (Pubitemid 39202467)
31. Qui Q, Overstreet JW, Todd H, Nakajima ST, Steward DR, Lasley BL. Total urinary follicle stimulating hormone as a biomarker for detection of early pregnancy and peri implantation spontaneous abortion. Environ Health Perspect 1997;105:862-866. (Pubitemid 27487778)
32. Taussky HH. A microcolorimetric determination of creatinine in urine by the Jaffe reaction. J Biol Chem 1954;208:853-861.
33. Brantley PJ, Waggoner CD, Jones GN, Rappaport NB. A Daily Stress Inventory: development, reliability, and validity. J Behav Med 1987;10:61-74. (Pubitemid 17059109)
34. Woods NF, Smith-DiJulio K, Percival DB, Mitchell ES. Cortisol levels across the menopausal transition: observations from the Seattle Midlife Women's Health Study. Menopause 2009;16:708-718.
35. Pinheiro J, Bates D, DebRoy S, Sarkar D. nlme: linear and nonlinear mixed effects models, R package version 3.1. 2005:1-66.
36. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2005. Available at: http://www.R-project.org.
37. Sarkar D. Lattice: lattice graphics. R package version 0.12-11.
38. Pinheiro J, Bates D. Mixed-Effects Models in S and S-PLUS. New York: Springer, 2000.
39. Hox J. Multilevel Analysis: Techniques and Applications. Mahwah, NJ: Lawrence Erlbaum Associates, 2002.
40. Woods NF, Smith-DiJulio K, Percival DB, Tao EY, Mariella A, Mitchell ES. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2008;15:223-232. (Pubitemid 351354981)
41. Lundberg U, Frankenhauser M. Stress and workload of men and women in high-ranking positions. J Occup Health Psychol 1999;4:142-151.
42. Cheng Y, Kawachi I, Coakley E, Schwartz J, Colditz G. Association between psychosocial work characteristics and health functioning in American women: prospective study. BMJ 2000;320:1432-1436. (Pubitemid 30311670)
43. Walters V. Stress, anxiety, and depression: women's accounts of their health problems. Soc Sci Med 1993;36:393-402. (Pubitemid 23078764)